← Leaderboards
David S Stephens
Emory University
$107,429,191
Attributed
$135,160,404
Total exposure
37
Grants
33
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $23.5M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$164,963,927 · 40
By mechanism
UL1$78,412,361 · 23
UM1$69,472,309 · 1
KL2$5,756,227 · 2
R01$4,390,383 · 3
P20$2,824,100 · 5
TL1$2,371,319 · 2
Top collaborators
- Kathleen Maletic Neuzil21 shared
- Yih-Ling Tzeng3 shared
- Jorge Eugenio Vidal3 shared
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingProgramsClinical ResearchCommunitiesInstitutionUnited States National Institutes Of HealthCollaborationsEthicsUniversitiesLeadershipFundingScientistPublicationsAreaInnovationInstitutesTranslational ResearchTranslatingMentorsCareer DevelopmentEnsureFutureElementsClinical Trials
Grant awards (113)
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$8,427,829
UM1 · FY2025 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$6,111,537
UM1 · FY2024 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$6,113,687
UM1 · FY2023 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$2,579,232
UM1 · FY2023 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$450,030
UM1 · FY2023 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$245,921
UM1 · FY2023 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$11,669,860
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$5,617,284
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$2,969,015
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$2,018,048
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$589,574
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$379,095
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - COVAIL DMID #22-0004$240,086
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$38,988
UM1 · FY2022 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$6,372,793
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Mix & Match DMID #21-0012 {Supplement #7}$3,094,264
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Gritstone, Variant, & Pediatric Vaccine Trials$2,577,219
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Momi-Vax DMID #21-0004 {Supplement #6}$2,253,969
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$933,971
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Moderna Boost {Supplement #5}$472,962
UM1 · FY2021 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$2,844,792
UM1 · FY2020 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$2,492,267
UM1 · FY2020 · AI · contact PI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)$979,886
UM1 · FY2020 · AI · contact PI
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE$164,128
R21 · FY2020 · AI
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE$157,385
R21 · FY2019 · AI
Dissemination of macrolide resistance elements in Streptococcus pneumoniae$75,599
R21 · FY2019 · AI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$5,147,598
UL1 · FY2016 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$730,503
KL2 · FY2016 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$249,741
TL1 · FY2016 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$5,166,612
UL1 · FY2015 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$247,033
TL1 · FY2015 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$228,046
KL2 · FY2015 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$33,442
UL1 · FY2015 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$5,168,749
UL1 · FY2014 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$711,750
KL2 · FY2014 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$244,395
TL1 · FY2014 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$104,250
UL1 · FY2014 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$4,839,297
UL1 · FY2013 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$630,513
KL2 · FY2013 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$241,758
TL1 · FY2013 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$5,378,765
UL1 · FY2012 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$586,752
KL2 · FY2012 · TR · contact PI
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal$243,218
TL1 · FY2012 · TR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,371,364
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,725,447
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,891,157
UL1 · FY2011 · RR · contact PI
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$667,433
UL1 · FY2011 · RR · contact PI
Atlanta Clinical and Translational Science Institute (KL2)$591,870
KL2 · FY2011 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$499,788
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$293,558
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$293,557
UL1 · FY2011 · RR · contact PI
Atlanta Clinical and Translational Science Institute (TL1)$236,384
TL1 · FY2011 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,425,620
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,278,760
UL1 · FY2010 · RR · contact PI
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$1,464,917
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,247,893
UL1 · FY2010 · RR · contact PI
Atlanta Clinical and Translational Science Institute (KL2)$591,870
KL2 · FY2010 · RR · contact PI
Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae$371,481
R01 · FY2010 · AI · contact PI
Atlanta Clinical and Translational Science Institute (TL1)$233,889
TL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$217,025
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$217,025
UL1 · FY2010 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,443,780
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,614,814
UL1 · FY2009 · RR · contact PI
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$1,435,590
UL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$998,826
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$900,876
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$769,041
UL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$599,998
UL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (KL2)$591,871
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$502,614
UL1 · FY2009 · RR · contact PI
Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae$375,233
R01 · FY2009 · AI · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$314,668
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$314,667
UL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (TL1)$214,516
TL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,000
UL1 · FY2009 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,439,787
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,238,200
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,278,949
UL1 · FY2008 · RR · contact PI
ATLANTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$1,278,948
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$643,690
UL1 · FY2008 · RR · contact PI
Atlanta Clinical and Translational Science Institute (KL2)$576,669
KL2 · FY2008 · RR · contact PI
Molecular basis of mef-mediated antibiotic resistance in Streptococcus pneumoniae$372,633
R01 · FY2008 · AI · contact PI
Atlanta Clinical and Translational Science Institute (TL1)$233,710
TL1 · FY2008 · RR · contact PI
Atlanta Clinical and Translational Science Institute (UL1)$5,200,656
UL1 · FY2007 · RR · contact PI
Atlanta Clinical and Translational Science Institute (KL2)$516,383
KL2 · FY2007 · RR · contact PI
Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae$370,045
R01 · FY2007 · AI · contact PI
Meningococcal Lipooligosaccharide & Mucosal Pathogenesis$242,130
R01 · FY2007 · AI · contact PI
Atlanta Clinical and Translational Science Institute (TL1)$226,675
TL1 · FY2007 · RR · contact PI
EXPLORATORY CENTER FOR VACCINOLOGY RESEARCH$577,893
P20 · FY2006 · RR · contact PI
Meningococcal Lipooligosaccharide & Mucosal Pathogenesis$249,515
R01 · FY2006 · AI · contact PI
CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE ADVANCEMENT AT EMORY$229,498
P20 · FY2006 · RR · contact PI
Center for Clinical and Translational Science Advancement at Emory$229,498
P20 · FY2006 · RR · contact PI
Regulation of Capsule Biosynthesis in N. meningitidis$218,737
R01 · FY2006 · AI · contact PI
EXPLORATORY CENTER FOR VACCINOLOGY RESEARCH (RMI)$40,116
P51 · FY2006 · RR · contact PI
EXPLORATORY CENTER FOR VACCINOLOGY RESEARCH$608,799
P20 · FY2005 · RR
Clinical Research Curriculum Award$300,000
K30 · FY2005 · RR
Meningococcal Lipooligosaccharide &Mucosal Pathogenesis$254,524
R01 · FY2005 · AI
Regulation of Capsule Biosynthesis in N. meningitidis$224,000
R01 · FY2005 · AI
EXPLORATORY CENTER FOR VACCINOLOGY RESEARCH$589,206
P20 · FY2004 · RR
Exploratory Center for Vaccinology Research (RMI)$589,206
P20 · FY2004 · RR
Meningococcal Lipooligosaccharide &Mucosal Pathogenesis$254,477
R01 · FY2004 · AI
Regulation of Capsule Biosynthesis in N. meningitidis$224,000
R01 · FY2004 · AI
CLINICAL RESEARCH CURRICULUM AWARD$200,000
K30 · FY2004 · HL
Meningococcal Lipooligosaccharide &Mucosal Pathogenesis$269,349
R01 · FY2003 · AI
Regulation of Capsule Biosynthesis in N. meningitidis$224,000
R01 · FY2003 · AI
CLINICAL RESEARCH CURRICULUM AWARD$200,000
K30 · FY2003 · HL
Regulation of Capsule Biosynthesis in N. meningitidis$220,705
R01 · FY2002 · AI
CLINICAL RESEARCH CURRICULUM AWARD$200,000
K30 · FY2002 · HL
CLINICAL RESEARCH CURRICULUM AWARD$200,000
K30 · FY2001 · HL
MENINGOCOCCAL LIPOOLIGOSACCHARIDE &MUCOSAL PATHOGENESIS$197,119
R01 · FY2001 · AI
CLINICAL RESEARCH CURRICULUM AWARD$200,000
K30 · FY2000 · HL
MENINGOCOCCAL LIPOOLIGOSACCHARIDE &MUCOSAL PATHOGENESIS$191,448
R01 · FY2000 · AI
REGULATION OF CAPSULE BIOSYNTHESIS IN N MENINGITIDIS$130,987
R01 · FY2000 · AI